NASDAQ:DRAD Digirad (DRAD) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$4.71▼$4.7650-Day Range$2.79▼$4.6552-Week Range$1.99▼$8.84Volume2,862 shsAverage Volume485,592 shsMarket Capitalization$22.42 millionP/E RatioN/ADividend Yield46.71%Price TargetN/A Stock AnalysisStock AnalysisCompetitorsTrendsStock AnalysisCompetitorsTrends Get Digirad alerts: Email Address Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Digirad Stock (NASDAQ:DRAD)Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through five segments: Diagnostic Services, Diagnostic Imaging, Mobile Healthcare, Building and Construction, and Real Estate and Investments. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. It also develops, sells, and maintains solid-state gamma cameras, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages real estate assets and investments. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia.Read More Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. DRAD Stock News HeadlinesJanuary 7, 2024 | nasdaq.comApril 19th Options Now Available For Karuna Therapeutics (KRTX)May 20, 2023 | cbsnews.com2 girls dead, 1 hospitalized after possible overdoses at high schoolJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.April 23, 2023 | usatoday.comConnecticut teachers thought 5-year-old boy was just 'playing dead' before he died, lawsuit claimsJanuary 16, 2023 | nypost.comLisa Marie Presley dead at 54 after cardiac arrest: ‘My beautiful daughter’January 14, 2023 | foxnews.comRock icon Jeff Beck dead at 78October 12, 2022 | businesswire.comGlobal Nuclear Medicine Equipment Market Report to 2030 - Featuring Siemens Healthineers, Fujifilm Holdings, Canon and Digirad Among Others - ResearchAndMarkets.com - Business WireOctober 11, 2022 | finance.yahoo.comGlobal Single Photon Emission Computed Tomography (SPECT) Market to Reach $2.7 Billion by 2027 - Yahoo FinanceJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.October 10, 2022 | prnewswire.com3D Vascular Ultrasound Imaging Market to record USD 344.17 Mn incremental growth; North America to have a significant share -- Technavio - PR NewswireOctober 7, 2022 | finance.yahoo.comOutlook on the Nuclear Medicine Equipment Global Market to 2030 - Rising Adoption of Nuclear Medicine Equipment and Emergence of Innovative & Advanced Equipment is Driving Growth - Yahoo FinanceAugust 26, 2022 | benzinga.comGlobal Single Photon Emission Computed Tomography (SPECT) Market Report 2022-2026: Hybrid SPECT Systems W - BenzingaAugust 25, 2022 | finance.yahoo.comGlobal Single Photon Emission Computed Tomography (SPECT) Market Report 2022: Market to Reach $2.5 Billion by 2026 - SPECT Dominates the Nuclear Medicine Market - Yahoo FinanceAugust 17, 2022 | streetinsider.comMD Office Solutions, LLC, acquires Antigua Medical Services, LLC; a Cardiac Mobile Imaging Company in Arizona - StreetInsider.comAugust 12, 2022 | seekingalpha.comStar Equity Holdings, Inc. (STRR) CEO Rick Coleman on Q2 2022 Results - Earnings Call Transcript - Seeking AlphaJuly 19, 2022 | businesswire.comGlobal Mobile Medical Imaging Services Market Report (2022 to 2027) - Transition of Diagnostic Image Processing Techniques from 2D to 3D Presents Opportunities - ResearchAndMarkets.com - Business WireJuly 16, 2022 | streetinsider.comForm 10-K SOLITRON DEVICES INC For: Feb 28 - StreetInsider.comJune 9, 2022 | benzinga.comGlobal Mobile Imaging Services Market Report 2022-2026: Rise of Home Healthcare - The Cornerstone for the - BenzingaSee More Headlines Receive DRAD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Digirad and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/18/2020Today7/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical Equipment Sub-IndustryN/A Current SymbolNASDAQ:DRAD CUSIPN/A CIK707388 Webwww.digirad.com Phone858-726-1600FaxN/AEmployees618Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.35) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,630,000.00 Net Margins-5.32% Pretax MarginN/A Return on Equity-3.75% Return on Assets-0.85% Debt Debt-to-Equity Ratio0.88 Current Ratio1.27 Quick Ratio0.91 Sales & Book Value Annual Sales$114.18 million Price / Sales0.20 Cash Flow$7.10 per share Price / Cash Flow0.69 Book Value$10.30 per share Price / Book0.48Miscellaneous Outstanding Shares4,760,000Free FloatN/AMarket Cap$23.32 million OptionableNot Optionable Beta0.18 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Matthew Gabel Molchan (Age 53)Pres, CEO & Director Comp: $705.96kMr. David James Noble (Age 50)CFO & COO Comp: $495.77kMr. Martin B. Shirley (Age 58)Pres of Digirad Imaging Solutions Comp: $427.94kMs. Hannah BibleVP of Legal & Fin.Mr. Bob HalbertSr. Director of Human ResourceKey CompetitorsHyperfineNASDAQ:HYPRVivani MedicalNASDAQ:VANIMovanoNASDAQ:MOVEelectroCoreNASDAQ:ECORPrecision OpticsNASDAQ:POCIView All Competitors DRAD Stock Analysis - Frequently Asked Questions How were Digirad's earnings last quarter? Digirad Co. (NASDAQ:DRAD) issued its quarterly earnings results on Wednesday, November, 18th. The medical equipment provider reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of $0.15 by $0.34. The medical equipment provider had revenue of $30.35 million for the quarter. Digirad had a negative trailing twelve-month return on equity of 3.75% and a negative net margin of 5.32%. When did Digirad's stock split? Digirad's stock reverse split on the morning of Wednesday, June 5th 2019. The 1-10 reverse split was announced on Friday, May 31st 2019. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, June 4th 2019. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What is Matt Molchan's approval rating as Digirad's CEO? 26 employees have rated Digirad Chief Executive Officer Matt Molchan on Glassdoor.com. Matt Molchan has an approval rating of 70% among the company's employees. 57.0% of employees surveyed would recommend working at Digirad to a friend. What other stocks do shareholders of Digirad own? Based on aggregate information from My MarketBeat watchlists, some other companies that Digirad investors own include Gilead Sciences (GILD), AT&T (T), Exelixis (EXEL), Enphase Energy (ENPH), OPKO Health (OPK), Rigel Pharmaceuticals (RIGL) and AcelRx Pharmaceuticals (ACRX). This page (NASDAQ:DRAD) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Digirad Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Digirad With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.